These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9526736)

  • 41. Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma.
    Anand A; Anand A; Anand N
    Cancer; 1996 May; 77(9):1959-60. PubMed ID: 8646700
    [No Abstract]   [Full Text] [Related]  

  • 42. [5-fluorouracile and cisplatinum combination chemotherapy for metastatic squamous-cell anal cancer].
    Faivre C; Rougier P; Ducreux M; Mitry E; Lusinchi A; Lasser P; Elias D; Eschwege F
    Bull Cancer; 1999 Oct; 86(10):861-5. PubMed ID: 10572237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Secondary metastasis after excision of oral squamous cancer without local recurrence].
    Yamamoto E; Miyakawa A; Hiratsuka H; Kumagai S; Kohama G
    Gan No Rinsho; 1989 Jun; 35(7):815-24. PubMed ID: 2472496
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Combined chemotherapy in esophageal carcinoma-the effect of PF (A) P therapy (peplomycin, 5-fluorouracil, (adriamycin), cisplatin)].
    Toda H; Tsujinaka T; Kido Y; Ogawa M; Shiozaki H; Miyamoto T; Kambayashi J; Murata A; Kobayashi K; Nishiyama K
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):855-8. PubMed ID: 2469397
    [No Abstract]   [Full Text] [Related]  

  • 45. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
    Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K
    Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma.
    Shin DM; Fossella FV; Umsawasdi T; Murphy WK; Chasen MH; Walsh G; Komaki R; McMurtrey MJ; Hong WK
    Cancer; 1995 Dec; 76(11):2230-6. PubMed ID: 8635025
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpression of p53 protein in squamous cell carcinoma of buccal mucosa and tongue in Taiwan: an immunohistochemical and clinicopathological study.
    Yan JJ; Tzeng CC; Jin YT
    J Oral Pathol Med; 1996 Feb; 25(2):55-9. PubMed ID: 8667256
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
    Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
    Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Combined CDDP-THP-PEP chemotherapy (PTP therapy) for head and neck squamous cell carcinoma--a group study].
    Sugasawa M; Nibu K; Ichimura K; Kaga K; Asai M; Senba T; Yamasoba T; Tsunoda K; Abe K; Kobayashi T
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):969-74. PubMed ID: 8002635
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heat shock protein and p53 expression in head and neck squamous cell carcinoma.
    Gandour-Edwards R; Trock BJ; Gumerlock P; Donald PJ
    Otolaryngol Head Neck Surg; 1998 May; 118(5):610-5. PubMed ID: 9591858
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Retrospective analysis on prognostic impact of adjuvant chemotherapy in the patients with advanced and resectable oral squamous cell carcinoma.
    Kurita H; Koike T; Miyazawa H; Uehara S; Kobayashi H; Kurashina K
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):915-21. PubMed ID: 16835480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value of multidrug resistance 1, glutathione-S-transferase-pi and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapy.
    Hsu CH; Chen CL; Hong RL; Chen KL; Lin JF; Cheng AL
    Oncology; 2002; 62(4):305-12. PubMed ID: 12138237
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.
    Gasparini G; Bevilacqua P; Bonoldi E; Testolin A; Galassi A; Verderio P; Boracchi P; Guglielmi RB; Pezzella F
    Clin Cancer Res; 1995 Nov; 1(11):1375-83. PubMed ID: 9815934
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preoperative thermochemotherapy of oral cancer using magnetic induction hyperthermia (Implant Heating System: IHS).
    Tohnai I; Goto Y; Hayashi Y; Ueda M; Kobayashi T; Matsui M
    Int J Hyperthermia; 1996; 12(1):37-47. PubMed ID: 8676007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multidisciplinary approach in advanced cancer of the oral cavity: outcome with neoadjuvant chemotherapy according to intention-to-treat local therapy. A phase II study.
    Grau JJ; Domingo J; Blanch JL; Verger E; Castro V; Nadal A; Alós L; Estapé J
    Oncology; 2002; 63(4):338-45. PubMed ID: 12417788
    [TBL] [Abstract][Full Text] [Related]  

  • 56. P-glycoprotein expression in squamous cell carcinoma of the oral and maxillofacial region.
    Xie ZJ; Yang XF; Gu ZY; Wu QL
    Chin J Dent Res; 2000 May; 3(1):23-6. PubMed ID: 11314336
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Combination chemotherapy with 254-S, ifosfamide and peplomycin for advanced or recurrent cervical cancer].
    Hirabayashi K; Okada E; Nakazuma Y; Akamatsu Y; Sezaki H; Ohta M; Nakanishi Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Mar; 44(3):341-8. PubMed ID: 1376759
    [TBL] [Abstract][Full Text] [Related]  

  • 58. p53 and bcl-2 expression in locally advanced squamous cell head-neck cancer treated with platinum based chemotherapy and radiotherapy.
    Giatromanolaki A; Koukourakis M; Zaramboukas T; Skordalaki A; Arapantoni P; Georgoulias V; Fountzilas G
    Anticancer Res; 1998; 18(6B):4685-92. PubMed ID: 9891541
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The proliferative activity in oral epithelial dysplasia analyzed by proliferating cell nuclear antigen immunostaining and argyrophilic nucleolar organizer region staining.
    Kobayashi I; matsuo K; Ozeki S; Ohishi M; Ishibashi Y; Sakai H
    Hum Pathol; 1995 Aug; 26(8):907-13. PubMed ID: 7635453
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Squamous cell carcinoma, basal cell carcinoma].
    Ikeda S; Suzuki T; Kiyohara Y; Kuramochi A
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1293-301. PubMed ID: 7688499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.